Intended for healthcare professionals

Editorials

Will you still need me, will you still screen me, when I'm past 64?

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7115.1032 (Published 25 October 1997) Cite this as: BMJ 1997;315:1032

Breast screening policy is based on ageism

  1. Graham C Sutton, Senior clinical lecturera
  1. a Nuffield Institute for Health, Leeds LS2 9PL

    Breast screening policy in Britain is based on women's age, as it should be. Age is the most important risk factor for breast cancer, and in younger women the health gain from screening is vanishingly small. A lower age limit is therefore rational. But when age related decisions are irrational or inequitable, they may reflect ageism. Is this the case with the upper limit for breast screening?

    The NHS screening service follows the recommendation in the Forrest report that in view of poor response rates there is insufficient benefit from offering screening to women aged 65 and over, though it may be available on request.1 This recommendation was based on the Utrecht study and the United Kingdom trial,2 3 both of which apparently showed a rapid fall in acceptance of repeated screening over 65.1 In Sweden, by contrast, uptake was 80% to age 74.4 However, neither the Utrecht nor the British trial recruited women over 65. Forrest presumably meant the Nijmegen study, where women …

    View Full Text

    Log in

    Log in through your institution

    Subscribe

    * For online subscription